factually
Index/Topics/Alzheimer's Blood Biomarkers 2025-2026

Alzheimer's Blood Biomarkers 2025-2026

The use of blood-based biomarkers for Alzheimer's disease, including plasma phosphorylated tau and amyloid-related ratios, and their validation and approval by the FDA for clinical use.

Fact-Checks

1 result
Jan 28, 2026
Most Viewed

What evidence exists for routine blood tests to detect Alzheimer's and how close are they to clinical use?

for Alzheimer’s—chiefly plasma phosphorylated tau (p-tau) and amyloid-related ratios—have moved from research curiosities to validated clinical tools: the approved at least one plasma test in 2025–202...